Intravenous news: Medpage Today report “The summer of 2012 may turn out to be the worst year ever for Lyme disease in the northeastern United States because of recent shifts in the acorn and white-footed mouse populations, even as researchers are making advances in the understanding and treatment of refractory cases.
Lyme disease results from the bite of a tick infected with the spirochete Borrelia burgdorferi. It typically manifests at first with the expanding rash known as erythema migrans. Many patients then develop a severe flu-like illness, with muscle aches, fever, chills, and lethargy.
Some infected individuals go on to develop intermittent arthritis, usually of the large joints, that can require extensive antibiotic treatment. And in an unfortunate few, even after 3 months of oral and intravenous antibiotics, the arthritis can persist for years.”